Stephen L. Rawlings

Array ( [id] => 5367130 [patent_doc_number] => 20090304689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'METHODS FOR THE IDENTIFICATION OF POLYPEPTIDE ANTIGENS ASSOCIATED WITH DISORDERS INVOLVING ABERRANT CELL PROLIFERATION AND COMPOSITIONS USEFUL FOR THE TREATMENT OF SUCH DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/364202 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30732 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304689.pdf [firstpage_image] =>[orig_patent_app_number] => 12364202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484884 [patent_doc_number] => 20090274649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Bispecific Antibody Point Mutations for Enhancing Rate of Clearance' [patent_app_type] => utility [patent_app_number] => 12/352632 [patent_app_country] => US [patent_app_date] => 2009-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17321 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274649.pdf [firstpage_image] =>[orig_patent_app_number] => 12352632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238687 [patent_doc_number] => 08603476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Humanized anti-human α9-integrin antibody' [patent_app_type] => utility [patent_app_number] => 12/812341 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10480 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12812341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514117 [patent_doc_number] => 20090214423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'SELECTIVE TARGETING OF TUMOR VASCULATURE USING RADIOLABELLED ANTIBODY MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/350346 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19099 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214423.pdf [firstpage_image] =>[orig_patent_app_number] => 12350346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264907 [patent_doc_number] => 20090117592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Altered Intracellular Localization of BRK/Sik Protein Tyrosine Kinase in Human Prostate Tumors' [patent_app_type] => utility [patent_app_number] => 12/349781 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5775 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117592.pdf [firstpage_image] =>[orig_patent_app_number] => 12349781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514215 [patent_doc_number] => 20090214521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Bone morphogenetic protein-2 in the treatment and diagnosis of cancer' [patent_app_type] => utility [patent_app_number] => 12/346266 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24019 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214521.pdf [firstpage_image] =>[orig_patent_app_number] => 12346266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538705 [patent_doc_number] => 20090220510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Specific binding proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/317683 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 59547 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220510.pdf [firstpage_image] =>[orig_patent_app_number] => 12317683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729112 [patent_doc_number] => 08101372 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Diagnosis and therapy of cancer using SGP28-related molecules' [patent_app_type] => utility [patent_app_number] => 12/343170 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 27380 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101372.pdf [firstpage_image] =>[orig_patent_app_number] => 12343170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7491488 [patent_doc_number] => 08030454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Anti-hedgehog antibodies' [patent_app_type] => utility [patent_app_number] => 12/341910 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33540 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030454.pdf [firstpage_image] =>[orig_patent_app_number] => 12341910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533051 [patent_doc_number] => 20090232839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'MELANOMA ASSOCIATED PEPTIDE ANALOGUES AND VACCINES AGAINST MELANOMA' [patent_app_type] => utility [patent_app_number] => 12/337834 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10712 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232839.pdf [firstpage_image] =>[orig_patent_app_number] => 12337834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8081037 [patent_doc_number] => 08147836 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins' [patent_app_type] => utility [patent_app_number] => 12/337140 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 3 [patent_no_of_words] => 22150 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/147/08147836.pdf [firstpage_image] =>[orig_patent_app_number] => 12337140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487423 [patent_doc_number] => 20110236380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'LIGANDS THAT BIND IL-13' [patent_app_type] => utility [patent_app_number] => 13/131438 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31524 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236380.pdf [firstpage_image] =>[orig_patent_app_number] => 13131438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539999 [patent_doc_number] => 20090221804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'GBS Toxin Receptor Compositions and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/331067 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12265 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221804.pdf [firstpage_image] =>[orig_patent_app_number] => 12331067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434989 [patent_doc_number] => 20090169575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/329500 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 35657 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169575.pdf [firstpage_image] =>[orig_patent_app_number] => 12329500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232971 [patent_doc_number] => 08198410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors' [patent_app_type] => utility [patent_app_number] => 12/277919 [patent_app_country] => US [patent_app_date] => 2008-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35715 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198410.pdf [firstpage_image] =>[orig_patent_app_number] => 12277919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409546 [patent_doc_number] => 20090123444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Compositions and Methods for Treatment of Neoplastic Disease' [patent_app_type] => utility [patent_app_number] => 12/276941 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23149 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123444.pdf [firstpage_image] =>[orig_patent_app_number] => 12276941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270886 [patent_doc_number] => 20090074662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Cancerous Disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 12/313349 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18238 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074662.pdf [firstpage_image] =>[orig_patent_app_number] => 12313349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564108 [patent_doc_number] => 20090136961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancer' [patent_app_type] => utility [patent_app_number] => 12/313196 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40411 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136961.pdf [firstpage_image] =>[orig_patent_app_number] => 12313196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221147 [patent_doc_number] => 07608693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'High affinity human antibodies to human IL-4 receptor' [patent_app_type] => utility [patent_app_number] => 12/260307 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9478 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608693.pdf [firstpage_image] =>[orig_patent_app_number] => 12260307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9888783 [patent_doc_number] => 08975036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-10 [patent_title] => 'Methods for improved diagnosis of dysplasias' [patent_app_type] => utility [patent_app_number] => 12/289487 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11882 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12289487 [rel_patent_id] =>[rel_patent_doc_number] =>)